DR. DAVID C GORSULOWSKY MD NPI 1649272832

NPI Details

DR. David C Gorsulowsky, MD is a dermatology in Fremont, CA with 46 years of experience. The provider is a dermatologist is trained to diagnose and treat pediatric and adult patients with benign and malignant disorders of the skin, mouth, external genitalia, hair and nails, as well as a number of sexually transmitted diseases. The dermatologist has had additional training and experience in the diagnosis and treatment of skin cancers, melanomas, moles and other tumors of the skin, the management of contact dermatitis and other allergic and nonallergic skin disorders, and in the recognition of the skin manifestations of systemic (including internal malignancy) and infectious diseases. Dermatologists have special training in dermatopathology and in the surgical techniques used in dermatology. They also have expertise in the management of cosmetic disorders of the skin such as hair loss and scars and the skin changes associated with aging. DR. David C Gorsulowsky, MD NPI is 1649272832. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE IN NEW ORLEANS
Graduation Year:1980

The provider's business location address is:

39210 STATE ST
STE 218
FREMONT, CA
ZIP 94538-456
Phone: (510) 790-0477
Fax: (510) 790-1835

The NPI 1649272832 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Destruction of precancer skin growth, 2-14 growths (HCPCS:17003)
• Puraply am, per square centimeter (HCPCS:Q4196)
• Affinity, per square centimeter (HCPCS:Q4159)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Destruction of precancer skin growth, 1 growth (HCPCS:17000)
• Destruction of skin growth, 1-14 growths (HCPCS:17110)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Biopsy of related skin growth, first growth (HCPCS:11102)
• Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
• Removal of inflamed or infected skin, up to 10% of body surface (HCPCS:11000)
• Application of skin substitute graft to wound of trunk, arms, or legs, 25.0 sq cm or less of wound 100.0 sq cm or less (HCPCS:15271)
• Removal of tissue from wound, 20.0 sq cm or less (HCPCS:97597)
• Application of skin substitute graft to wound of face, scalp, eyelids, mouth, neck, ears, around eyes, genitals, hands, feet, fingers, or toes, 25.0 sq cm or less of wound 100.0 sq cm or less (HCPCS:15275)
• Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks (HCPCS:17311)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Simple or single drainage of skin abscess (HCPCS:10060)
• Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
• Biopsy of related skin growth, each additional growth (HCPCS:11103)
• Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or (HCPCS:G2212)
• Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks (HCPCS:17312)
• Injection, triamcinolone acetonide, not otherwise specified, 10 mg (HCPCS:J3301)
• New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
• Repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet by transferring skin, 10.0 sq cm or less (HCPCS:14040)
• Biopsy of ear (HCPCS:69100)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Pathology examination of specimen during surgery, first tissue block (HCPCS:88331)
• Injection into skin growth, 1-7 growths (HCPCS:11900)
• Repair of wound of eyelids, nose, ears, or lips by transferring skin, 10.0 sq cm or less (HCPCS:14060)
• Removal and microscopic exam of growth of trunk, arms, or legs, 1-5 tissue blocks (HCPCS:17313)
• Initial hospital inpatient care per day, typically 50 minutes (HCPCS:99222)
• Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm (HCPCS:13121)
• Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm (HCPCS:17262)
• Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Biopsy of eyelid (HCPCS:67810)
• Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
• Tissue fungi or parasites (HCPCS:87220)
• Biopsy of lip (HCPCS:40490)
• Shaving of skin growth of scalp, neck, hands, feet, or genitals, 0.5 cm or less (HCPCS:11305)
• Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm (HCPCS:17282)
• Melanoma (skin cancer) excision (HCPCS:NAN03)

The enumeration date for this NPI number is 6/1/2005 and was last updated on 3/13/2024.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.